%0 Journal Article %T PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients %A Schulze, Arik Bernard %A Schmidt, Lars Henning %J Journal of Thoracic Disease %D 2017 %B 2017 %9 %! PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients %K %X The better understanding of interactions between tumor and immune system (e.g., tumor-associated upregulation of PD-L1 to induce checkpoint for cytotoxic lymphocytes; Figure 1A ) gave rise to the development of immune modulating therapies. %U https://jtd.amegroups.org/article/view/12967 %V 9 %N 4 %P E384-E386 %@ 2077-6624